Canada Sets 2019 Target For Mandatory Adoption Of Single-Audit Program
This article was originally published in The Gray Sheet
The global Medical Device Single Audit Program will become the sole mechanism to demonstrate compliance with Canadian quality management system requirements beginning January 2019.
You may also be interested in...
After a long build up, four international regulatory authorities officially rolled out the Medical Device Single Audit Program pilot this month. Here are 10 things companies should know about the program.
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.